A small-molecule antagonist of human and murine CCR1 receptors

Expert Opinion on Investigational Drugs

Volumn 10, Issue 7, 2001, Pages 1387-1389

  Fernandez Botran, R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Chemokine; Chemokine antagonists; Chemokine receptors; Inflammation

Indexed keywords

AMIDE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR1 BLOCKING AGENT; CHEMOKINE RECEPTOR CCR3; RECEPTOR ANTIBODY; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; XANTHENE 9 CARBOXAMIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG INDUSTRY; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; MOLECULAR WEIGHT; MOUSE; NONHUMAN; RECEPTOR AFFINITY;

ANIMALS; HUMANS; MODELS, CHEMICAL; RECEPTORS, CHEMOKINE;

EID: 0034942627     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.10.7.1387     Document Type: Article

References (12)

1. Design, synthesis, and discovery of a novel CCR1 antagonist
2. The biology of chemokines and their receptors
3. The strategy of blocking the chemokine system to combat disease
4. The role of chemokine receptors in primary, effector, and memory immune responses
5. Blocking chemokine receptors
6. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-mediated neutrophil migraton
7. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
8. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
9. Discovery of novel non-peptide CCR1 receptor antagonists
10. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor
11. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils
12. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry